TrademarkDir
REPORTINGPHARM
LIVE

Serial Number

97884473

Owner

Health Strategy, LLC

Attorney

Annette P. Heller

First Use Date

May 30, 2024

Filing Date

Apr 12, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

REPORTINGPHARM Trademark

Serial Number: 97884473 • Registration: 7756507

REPORTINGPHARM is a trademark filed by Health Strategy, LLC on April 12, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Health Strategy, LLC (5 trademarks)

Peoria, IL 61602

Entity Type: 16

Trademark Details

Filing Date

April 12, 2023

Registration Date

April 8, 2025

First Use Anywhere

May 30, 2024

First Use in Commerce

May 30, 2024

Goods & Services

Providing temporary use of non-downloadable on-line, internet-based software platform enabling users to analyze a variety of information concerning pharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 8, 2025 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Apr 8, 2025 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 13, 2025 PREV
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Mar 13, 2025 CNTA
USE AMENDMENT ACCEPTED
Mar 13, 2025 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Dec 27, 2024 AUPC
USE AMENDMENT FILED
Dec 27, 2024 IUAF
TEAS AMENDMENT OF USE RECEIVED
Dec 27, 2024 EAAU
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 27, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 28, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 28, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 28, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2024 CRFA
ASSIGNED TO LIE
Oct 11, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 27, 2024 TROA
NOTICE OF REVIVAL - E-MAILED
Jun 27, 2024 NREV
PETITION TO REVIVE-GRANTED
Jun 27, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Jun 27, 2024 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 1, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 1, 2024 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 16, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 16, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 16, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 9, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 6, 2023 NWOS
NEW APPLICATION ENTERED
Apr 15, 2023 NWAP

Related Trademarks

More from this Owner

RX PRICE GUARD

RX PRICE GUARD

RX PRICE GUARD

RX PRICE GUARD

HEALTH STRATEGY RX MARKETPLACE PROCESS

HEALTH STRATEGY RX MARKETPLACE PROCESS

RX MARKETPLACE

RX MARKETPLACE

REPORTINGPHARM

REPORTINGPHARM

REPORTINGPHARM

REPORTINGPHARM